Understanding echinocandin resistance in the emerging pathogen Candida auris.

scientific article published on 9 April 2018

Understanding echinocandin resistance in the emerging pathogen Candida auris. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1128/AAC.00238-18
P932PMC publication ID5971591
P698PubMed publication ID29632013

P50authorAnuradha ChowdharyQ42337778
David S PerlinQ104479284
P2093author name stringYanan Zhao
Steven Park
Annie Lee
Milena Kordalewska
Indira Berrio
P2860cites workEffect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpointQ42545839
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.Q42687352
Candida auris-associated candidemia, South AfricaQ42712931
Candida auris candidemia in Kuwait, 2014.Q42787996
Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical featuresQ43521723
Candidemia caused by amphotericin B and fluconazole resistant Candida aurisQ44304263
Optimized 5-hour multiplex PCR test for the detection of tinea unguium: performance in a routine PCR laboratory.Q45234129
A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.Q50083987
Activity of CD101, a long-acting echinocandin, against clinical isolates of Candida aurisQ50145270
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016.Q50985111
Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species.Q53704744
Hospital transmitted Candida auris infections confirmed in the US.Q53762019
Use of an animal model of disseminated candidiasis in the evaluation of antifungal therapyQ81739235
Invasive Infections with Multidrug-Resistant Yeast Candida auris, ColombiaQ28818814
Multidrug-resistant Candida auris: 'new kid on the block' in hospital-associated infections?Q30245326
Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospitalQ33401940
Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globallyQ33704302
First three reported cases of nosocomial fungemia caused by Candida aurisQ34196357
New clonal strain of Candida auris, Delhi, IndiaQ34372060
First hospital outbreak of the globally emerging Candida auris in a European hospitalQ34543358
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological AnalysesQ34547546
New Fks hot spot for acquired echinocandin resistance in Saccharomyces cerevisiae and its contribution to intrinsic resistance of Scedosporium speciesQ35139501
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by VitekQ35586995
Evidence of genotypic diversity among Candida auris isolates by multilocus sequence typing, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and amplified fragment length polymorphism.Q35835357
Detection of amphotericin B resistance in Candida haemulonii and closely related species by use of the Etest, Vitek-2 yeast susceptibility system, and CLSI and EUCAST broth microdilution methodsQ36022880
How to calculate sample size in animal studies?Q37303624
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?Q37335747
Current perspectives on echinocandin class drugsQ37554055
Multidrug-Resistant Candida haemulonii and C. auris, Tel Aviv, IsraelQ37664411
The Eagle-like effect of echinocandins: what's in a name?Q38153458
Mechanisms of echinocandin antifungal drug resistanceQ38550402
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values.Q39092102
Isolates of the emerging pathogen Candida auris present in the UK have several geographic origins.Q39092125
First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemiaQ39092138
Incidence, characteristics and outcome of ICU-acquired candidemia in IndiaQ39092143
Multidrug-resistant endemic clonal strain of Candida auris in India.Q39092162
Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida aurisQ39092215
Pharmacodynamic Optimization for Treatment of Invasive Candida auris InfectionQ39092240
The first cases of Candida auris candidaemia in OmanQ39092264
Nosocomial fungemia by Candida auris: First four reported cases in continental Europe.Q39092317
Whole genome sequencing of emerging multidrug resistant Candida auris isolates in India demonstrates low genetic variationQ39092330
In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies.Q39657947
Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrationsQ39954432
Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpointsQ41787736
Isolation of Candida auris from nine patients in Central America: Importance of accurate diagnosis and susceptibility testingQ41994530
Role for Fks1 in the intrinsic echinocandin resistance of Fusarium solani as evidenced by hybrid expression in Saccharomyces cerevisiaeQ42035911
P407language of work or nameEnglishQ1860
P921main subjectCandida aurisQ26816853
emerging pathogenQ108429945
P577publication date2018-04-09
P1433published inAntimicrobial Agents and ChemotherapyQ578004
P1476titleUnderstanding echinocandin resistance in the emerging pathogen Candida auris.

Reverse relations

cites work (P2860)
Q90618019Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus
Q92320618Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris
Q64270951Comparison of 21-Plex PCR and API 20C AUX, MALDI-TOF MS, and rDNA Sequencing for a Wide Range of Clinically Isolated Yeast Species: Improved Identification by Combining 21-Plex PCR and API 20C AUX as an Alternative Strategy for Developing Countries
Q90572938Detection of Candida auris antifungal drug resistance markers directly from clinical skin swabs
Q89665271Drug resistance and tolerance in fungi
Q99709014Echinocandins as Biotechnological Tools for Treating Candida auris Infections
Q92376812Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen
Q58598193Epidemiology, clinical characteristics, resistance, and treatment of infections by
Q96155834Genetic Heterogeneity of Australian Candida auris Isolates: Insights From a Nonoutbreak Setting Using Whole-Genome Sequencing
Q64226654Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS
Q93088245Identification of Drug Resistant Candida auris
Q64084323Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen
Q58693906MALDI-TOF MS Applications to the Detection of Antifungal Resistance: State of the Art and Future Perspectives
Q92752608Molecular Diagnostics in the Times of Surveillance for Candida auris
Q92666321Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen
Q91623044Nitroglycerin-Citrate-Ethanol Catheter Lock Solution Is Highly Effective for In Vitro Eradication of Candida auris Biofilm
Q58609308Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.
Q92071802Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris
Q93166142Something wicked this way comes: What health care providers need to know about Candida auris
Q64070550The global challenge of Candida auris in the intensive care unit
Q94451620Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses
Q55689919Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance.
Q90204317Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris

Search more.